Literature DB >> 16765476

C/EBP alpha mutations in lung cancer.

Daniel B Costa, Tajhal Dayaram, Francesco D'Alo, Bas J Wouters, Daniel G Tenen, Matthew Meyerson, Ming-Sound Tsao, Balazs Halmos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16765476     DOI： 10.1016/j.lungcan.2006.04.011

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  13 in total

1.  15-Hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3beta and a tumor suppressor in lung cancer.

Authors:  Guosheng Huang; Rosana Eisenberg; Min Yan; Stefano Monti; Earl Lawrence; Pingfu Fu; Jaclyn Walbroehl; Ester Löwenberg; Todd Golub; Jaime Merchan; Daniel G Tenen; Sanford D Markowitz; Balazs Halmos
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

Review 2.  A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood.

Authors:  A R Lourenço; P J Coffer
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

Review 3.  Lineage factors and differentiation states in lung cancer progression.

Authors:  W K C Cheung; D X Nguyen
Journal:  Oncogene       Date:  2015-03-30       Impact factor: 9.867

4.  Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing.

Authors:  Daniela S Basseres; Francesco D'Alò; Beow Y Yeap; Ester C Löwenberg; David A Gonzalez; Hiroyuki Yasuda; Tajhal Dayaram; Olivier N Kocher; John J Godleski; William G Richards; Matthew Meyerson; Susumu Kobayashi; Daniel G Tenen; Balázs Halmos; Daniel B Costa
Journal:  Lung Cancer       Date:  2012-02-16       Impact factor: 5.705

5.  A Cell-Based High-Throughput Screening for Inducers of Myeloid Differentiation.

Authors:  Hanna S Radomska; Finith Jernigan; Sohei Nakayama; Susan E Jorge; Lijun Sun; Daniel G Tenen; Susumu S Kobayashi
Journal:  J Biomol Screen       Date:  2015-06-24

6.  Characterization and functional analysis of the human microRNA let-7a2 promoter in lung cancer A549 cell lines.

Authors:  Hengyun Guan; Pengju Zhang; Chang Liu; Ju Zhang; Zhaoqin Huang; Weiwen Chen; Zhaobo Chen; Nana Ni; Qingwei Liu; Anli Jiang
Journal:  Mol Biol Rep       Date:  2011-03-02       Impact factor: 2.316

7.  Restoration of C/EBPα in dedifferentiated liposarcoma induces G2/M cell cycle arrest and apoptosis.

Authors:  Yuhsin V Wu; Tomoyo Okada; Penelope DeCarolis; Nicholas Socci; Rachael O'Connor; Rula C Geha; C Joy Somberg; Cristina Antonescu; Samuel Singer
Journal:  Genes Chromosomes Cancer       Date:  2011-12-14       Impact factor: 5.006

8.  Immunohistochemical analysis of C/EBPalpha in non-small cell lung cancer reveals frequent down-regulation in stage II and IIIA tumors: a correlative study of E3590.

Authors:  Daniel B Costa; Sigui Li; Olivier Kocher; Richard H Feins; Steven M Keller; Joan H Schiller; David H Johnson; Daniel G Tenen; Balazs Halmos
Journal:  Lung Cancer       Date:  2007-01-18       Impact factor: 5.705

9.  Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.

Authors:  Mohd W Nasser; Jharna Datta; Gerard Nuovo; Huban Kutay; Tasneem Motiwala; Sarmila Majumder; Bo Wang; Saul Suster; Samson T Jacob; Kalpana Ghoshal
Journal:  J Biol Chem       Date:  2008-09-25       Impact factor: 5.157

10.  CCAAT/enhancer-binding protein-α suppresses lung tumor development in mice through the p38α MAP kinase pathway.

Authors:  Atsuyasu Sato; Norishige Yamada; Yuya Ogawa; Machiko Ikegami
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.